Regulation of the anti-tumour immune response by cancer-associated fibroblasts

Abstract The microenvironment of established tumours is often immunosuppressed, and this allows tumours to grow and disseminate without being eliminated by the patient's immune system. The recent FDA approval of immunotherapies such as ipilimumab and sipuleucel-T that directly activate the adap...

Ausführliche Beschreibung